Powered By
Overview
Vectical is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 2009. Vectical is used to treat mild to moderate plaque psoriasis in adults 18 years and older. Vectical is also… read more
Overview
Siliq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe psoriasis in adults. Siliq may be prescribed in cases where systemic therapy and phototherapy are… read more
Overview
Neoral is a prescription medication originally approved by the U.S. Food and Drug Administration (FDA) in 1983. Neoral is approved to treat severe psoriasis in adults who do not respond to other treatments.… read more
Overview
Erelzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Erelzi may be referred to by… read more
Overview
Calcitrene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis in adults. It is prescribed for individuals with mild to moderate plaque psoriasis and should not be…
Tremfya (guselkumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis…
read moreCimzia (certolizumab pegol) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque…
read moreSkyrizi (risankizumab-rzaa) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for adults with moderate to severe psoriasis…
read moreCosentyx (secukinumab) is a biologic medicine approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in…
read moreTaltz (ixekizumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in…
read more
Join
Your Privacy Choices
